Neurophet Appoints Globally Renowned Imaging AI Expert Dr. Lawrence N. Tanenbaum as Scientific Advisor
Former Vice President and Chief Technology Officer of RadNet, one of the largest outpatient imaging providers in the United States Appointment expected to strengthen clinical validation, global expansion, and competitiveness in neuroimaging AI...
Otis Appoints Ong Chew Seng as Managing Director, Singapore
SINGAPORE, May 20, 2026 /PRNewswire/ -- Otis Worldwide Corporation (NYSE: OTIS), the world's leading elevator and escalator manufacturing, installation, service and modernization company, today announced the appointment of Ong Chew Seng as Managing...
Antengene Appoints Dr. Bing Hou as Chief Scientific Officer to Lead Innovation-Driven R&D Strategy and Advance Next-Generation Pipeline
SHANGHAI and HONG KONG, May 20, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class...
The Hong Kong Chartered Governance Institute Announces Gill Meller's Appointment as President of The Chartered Governance Institute
HONG KONG, May 19, 2026 /PRNewswire/ -- The Hong Kong Chartered Governance Institute (HKCGI) is proud to announce the election of Gill Meller FCG HKFCG(PE) as the President of The Chartered Governance Institute (CGI), the global Institute of which...
NEC Vietnam Appoints New General Director to Advance Digital Innovation
HANOI, Vietnam, May 18, 2026 /PRNewswire/ -- NEC Vietnam announced the appointment of Yasushi Numakura as its new General Director, effective April 1, 2026. The appointment reflects NEC's continued commitment to expanding trusted technology...
Atisama Therapeutics Advances RB042 into Multiple Ascending Dose cohorts of Phase 1 Trial and Appoints Bernard Coulie as Chair of the Board
RB042 Phase 1 trial advances into multiple ascending dose study cohorts, demonstrating safety and tolerability to date. Dr. Coulie brings more than 25 years of international biopharma leadership and deep expertise in pulmonary disease to the Atisama...
OnCusp Therapeutics Appoints Anthony Kim as Chief Financial Officer
PRINCETON, N.J., May 14, 2026 /PRNewswire/ -- OnCusp Therapeutics, Inc., a clinical-stage biopharmaceutical company developing differentiated oncology therapies designed to translate cutting-edge innovation into clinically meaningful outcomes for...
EMA Partners Appoints Alicia Yi as Group Executive Advisor, Strengthening Executive Search & Leadership Advisory Capabilities Across APAC
SINGAPORE, May 13, 2026 /PRNewswire/ -- Global executive search and leadership advisory firm EMA Partners today announced that former Korn Ferry Vice Chair Alicia Yi has joined the firm as Group Executive Advisor, based in Singapore. Her appointment...
Zetaris Appoints Two Industry Heavyweights to Accelerate Global Growth
Former Hitachi Vantara executives Ashish Bhagat and Phil Vadon join as CFO and CRO, bringing a track record of building multi-hundred-million-dollar businesses from the ground up SAN FRANCISCO, May 12, 2026 /PRNewswire/ -- Zetaris, the Open Agentic...
Nona Biosciences Appoints Dr. Josh Xiao as Chief Scientific Officer to Advance Global Scientific Strategy and Innovation
CAMBRIDGE, Mass., May 7, 2026 /PRNewswire/ -- Nona Biosciences ("Nona" or the "Company"), a global biotechnology company advancing biotherapeutic discovery through innovative technology platforms, today announced the appointment of Dr. Josh Xiao as...